CSF2RB

Chr 22AR

colony stimulating factor 2 receptor subunit beta

Also known as: CD131, CDw131, IL3RB, IL5RB, SMDP5, betaGMR

The protein functions as the common beta chain of high-affinity receptors for interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor, controlling hematopoietic cell production and differentiation through JAK-STAT signaling pathways. Mutations cause autosomal recessive surfactant metabolism dysfunction, pulmonary type 5, presenting as pulmonary alveolar proteinosis. The gene shows moderate constraint against loss-of-function variants (LOEUF 0.44), indicating some intolerance to complete protein loss.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismARLOEUF 0.441 OMIM phenotype
Clinical SummaryCSF2RB
🧬
Gene-Disease Validity (ClinGen)
surfactant metabolism dysfunction, pulmonary, 5 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.24) despite low pLI — interpret in context.
📋
ClinVar Variants
322 VUS of 500 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.44LOEUF
pLI 0.176
Z-score 4.00
OE 0.24 (0.140.44)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
0.13Z-score
OE missense 0.98 (0.921.06)
518 obs / 526.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.24 (0.140.44)
00.351.4
Missense OE0.98 (0.921.06)
00.61.4
Synonymous OE1.15
01.21.6
LoF obs/exp: 8 / 32.7Missense obs/exp: 518 / 526.3Syn Z: -1.81
DN
0.7326th %ile
GOF
0.75top 25%
LOF
0.3162th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

VUS322
Likely Benign170
Conflicting3
322
VUS
170
Likely Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
0
0
0
Likely Pathogenic
0
0
0
0
0
VUS
13
296
8
5
322
Likely Benign
0
6
47
117
170
Benign
0
0
0
0
0
Conflicting
3
Total1330255122495

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CSF2RB · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →